543595 — EP Biocomposites Income Statement
0.000.00%
Last trade - 00:00- IN₹211.87m
- IN₹225.48m
- IN₹120.06m
- 46
- 47
- 15
- 26
Annual income statement for EP Biocomposites, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 29.5 | 80.6 | 71.3 | 114 | 120 |
| Cost of Revenue | |||||
| Gross Profit | 11.3 | 31 | 30.3 | 44.6 | 42.9 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 24.9 | 67.5 | 62.8 | 101 | 103 |
| Operating Profit | 4.6 | 13.1 | 8.51 | 13.1 | 16.6 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 4.64 | 11.7 | 8.14 | 15.7 | 14.2 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 3.58 | 8.09 | 5.76 | 11.5 | 10.3 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 3.58 | 8.09 | 5.76 | 11.5 | 10.3 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 3.58 | 8.09 | 5.76 | 11.5 | 10.3 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 2.13 | 4.81 | 3.43 | 6.84 | 6.13 |
| Dividends per Share |